Brain-computer interface (BCI) company Cognixion is a direct rival of Elon Musk’s Neuralink. Both are working to transform intent into action for disabled individuals. But the two companies are on different trajectories, according to Cognixion founder and CEO Andreas Forsland. While Musk’s Neuralink looks far ahead with implantable chips requiring surgery, Cognixion aims to help more people, sooner, with non-invasive alternatives.

Thank you for signing up!

By clicking submit, you agree to our terms of service and acknowledge we may use your information to send you emails, product samples, and promotions on this website and other properties. You can opt out anytime.

“Neuralink is an interesting technology, but it requires surgery, and most people are not going to volunteer for that,” Forsland told Observer. Only extreme use cases with high-needs neurological conditions, he added, would require it, and “any neurologist, if you don’t need an implant, they’re not going to prescribe one.”

On the contrary, Cognixion offers non-invasive BCI headsets that integrate into its own computer platform. Cognixion offers two non-invasive headsets equipped with augmented reality displays, Cognixion ONE and Axon-R, the latter of which was released at the recent AI for Good Global Summit in Geneva last month and is a derivative product of Cognixion ONE, which is already available for........

© Observer